Le Lézard
Classified in: Business, Covid-19 virus
Subjects: ERN, DIV

Great-West Lifeco reports first quarter 2020 results


This earnings news release for Great-West Lifeco Inc. should be read in conjunction with the Company's interim Management Discussion & Analysis (MD&A) and condensed consolidated interim unaudited Financial Statements for the period ended March 31, 2020, prepared in accordance with International Financial Reporting Standards (IFRS). These reports are available on greatwestlifeco.com under Financial Reports. Additional information relating to Lifeco is available on sedar.com. Readers are referred to the cautionary notes regarding Forward-Looking Information and Non-IFRS Financial Measures at the end of this release.  All figures are expressed in Canadian dollars, except as noted.

TSX:GWO

WINNIPEG, May 6, 2020 /CNW/ - Great-West Lifeco Inc. (Lifeco or the Company) today announced its first quarter 2020 results.

"As the emergence of the COVID-19 pandemic has impacted people and economies worldwide, we've focused on safeguarding the health and well-being of our employees, customers and communities. We responded quickly to support our clients and communities through a variety of deliberately deployed tools and advice to help them weather financial and personal challenges," said Paul Mahon, President and Chief Executive Officer, Great-West Lifeco Inc. "Lifeco is in a strong financial position and our operating companies have successfully navigated change and volatility in the past. We believe our strength, diversity and experience are powerful advantages as we respond to these challenges while continuing to focus on opportunities for growth."

Net earnings attributable to common shareholders (net earnings) were $342 million, or $0.37 per common share (EPS), for the first quarter of 2020 compared to $657 million, or $0.67 per common share, for the same quarter last year.  Base earnings for the first quarter of 2020 of $543 million or $0.59 per common share compared to $569 million or $0.58 per common share a year ago.

Common Shareholders

Q1 2020

Q1 2019

Base earnings(1)



Canada

$273

$257

United States

17

81

Europe

132

163

Capital and Risk Solutions

119

74

Lifeco Corporate

2

(6)

Total base earnings(1)

$543

$569




Items excluded from base earnings(2)

(201)

88

Net earnings

$342

$657







   Base EPS(1)

$0.59

$0.58

   Net EPS

$0.37

$0.67







   Base return on equity(1)

13.4%

11.0%

   Return on equity

10.3%

13.5%


(1)Represents a non-IFRS measure. Refer to the "Non-IFRS Financial Measures" section of the Company's first quarter of 2020 interim MD&A for additional details.


(2)Items excluded from base earnings are basis changes and management actions and market-related impacts. Refer to the "Non-IFRS Financial Measures" section of the Company's first quarter of 2020 interim MD&A for additional details.






Base EPS for the first quarter of 2020 of $0.59, increased 2% from $0.58 a year ago primarily due to business growth in Capital and Risk Solutions segment earnings partially offset by unrealized losses on seed capital investments and lower fee income due to the impact of a decline in the equity market levels since December 31, 2019.  Reported net EPS for the first quarter of 2020 was $0.37, down from $0.67 in 2019, primarily due to approximately $300 million of market-related impacts including unfavourable basis changes reflecting significant market declines and volatility in the first quarter of 2020 driven by the COVID-19 pandemic.

COVID-19 Pandemic Impacts

SEGMENTED OPERATING RESULTS
For reporting purposes, Lifeco's consolidated operating results are grouped into five reportable segments ? Canada, United States, Europe, Capital and Risk Solutions and Lifeco Corporate ? reflecting the management and corporate structure of the Company.  For more information, refer to the Company's first quarter of 2020 interim Management's Discussion and Analysis (MD&A).

CANADA

UNITED STATES

EUROPE

CAPITAL AND RISK SOLUTIONS

QUARTERLY DIVIDENDS
The Board of Directors approved a quarterly dividend of $0.438 per share on the common shares of Lifeco payable June 30, 2020 to shareholders of record at the close of business June 2, 2020.

In addition, the Directors approved quarterly dividends on Lifeco's preferred shares, as follows:

First Preferred Shares

Record Date

Payment Date

Amount, per share

Series F

June 2, 2020

June 30, 2020

$0.36875

Series G

June 2, 2020

June 30, 2020

$0.3250

Series H

June 2, 2020

June 30, 2020

$0.30313

Series I

June 2, 2020

June 30, 2020

$0.28125

Series L

June 2, 2020

June 30, 2020

$0.353125

Series M

June 2, 2020

June 30, 2020

$0.3625

Series N

June 2, 2020

June 30, 2020

$0.1360

Series O

June 2, 2020

June 30, 2020

$0.183123

Series P

June 2, 2020

June 30, 2020

$0.3375

Series Q

June 2, 2020

June 30, 2020

$0.321875

Series R

June 2, 2020

June 30, 2020

$0.3000

Series S

June 2, 2020

June 30, 2020

$0.328125

Series T

June 2, 2020

June 30, 2020

$0.321875

For purposes of the Income Tax Act (Canada), and any similar provincial legislation, the dividends referred to above are eligible dividends.

Selected financial information is attached.

GREAT-WEST LIFECO INC.
Great-West Lifeco is an international financial services holding company with interests in life insurance, health insurance, retirement and investment services, asset management and reinsurance businesses. We operate in Canada, the United States and Europe under the brands Canada Life, Empower Retirement, Putnam Investments, and Irish Life.  At the end of 2019, our companies had approximately 24,000 employees, 197,000 advisor relationships, and thousands of distribution partners ? all serving our more than 31 million customer relationships across these regions.

Great-West Lifeco and its companies have over $1.5 trillion in consolidated assets under administration as at March 31, 2020 and are members of the Power Corporation group of companies. Great-West Lifeco trades on the Toronto Stock Exchange (TSX) under the ticker symbol GWO. To learn more, visit greatwestlifeco.com.?

Basis of presentation
The condensed consolidated interim unaudited financial statements of Lifeco have been prepared in accordance with International Financial Reporting Standards (IFRS) unless otherwise noted and are basis for the figures presented in this release, unless otherwise noted.

Cautionary note regarding Forward-Looking Information
This release may contain forward-looking information.  Forward-looking information includes statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates" and other similar expressions or negative versions thereof.  These statements include, without limitation, statements about the Company's operations, business, financial condition, expected financial performance (including revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future actions by the Company, including statements made with respect to the expected benefits of acquisitions and divestitures, expected capital management activities and use of capital,  expected dividend levels, expected cost reductions and savings, the impact of regulatory developments on the Company's business strategy and growth objectives and the expected impact of the current pandemic health event resulting from the novel coronavirus (COVID-19) and related economic and market impacts on the Company's business operations, financial results and financial condition.  Forward-looking statements are based on expectations, forecasts, estimates, predictions, projections and conclusions about future events that were current at the time of the statements and are inherently subject to, among other things, risks, uncertainties and assumptions about the Company, economic factors and the financial services industry generally, including the insurance and mutual fund industries.  They are not guarantees of future performance, and the reader is cautioned that actual events and results could differ materially from those expressed or implied by forward-looking statements.  Whether or not actual results differ from forward-looking information may depend on numerous factors, developments and assumptions, including, without limitation, customer behaviour, the Company's reputation, market prices for products provided, sales levels, premium income, fee income, expense levels, mortality experience, morbidity experience, policy lapse rates, reinsurance arrangements, liquidity requirements, capital requirements, credit ratings, taxes, inflation, interest and foreign exchange rates, investment values, hedging activities, global equity and capital markets (including continued access to equity and debt markets), industry sector and individual debt issuers' financial conditions (including developments and volatility arising from the COVID-19 pandemic, particularly in certain industries that may comprise part of the Company's investment portfolio), business competition and other general economic, political and market factors in North America and internationally.  Many of these assumptions are based on factors and events that are not within the control of the Company and there is no assurance that they will prove to be correct.  Other important factors and assumptions that could cause actual results to differ materially from those contained in forward-looking statements include customer responses to new products, impairments of goodwill and other intangible assets, the Company's ability to execute strategic plans and changes to strategic plans, technological changes, breaches or failure of information systems and security (including cyber attacks), payments required under investment products, changes in local and international laws and regulations, changes in accounting policies and the effect of applying future accounting policy changes, unexpected judicial or regulatory proceedings, catastrophic events, continuity and availability of personnel and third party service providers, the Company's ability to complete strategic transactions and integrate acquisitions, unplanned material changes to the Company's facilities, customer and employee relations or credit arrangements, levels of administrative and operational efficiencies, and the severity, magnitude and impact of the COVID-19 pandemic (including the effects of the COVID-19 pandemic, and the effects of the governments' and other businesses' responses to the COVID-19 pandemic, on the economy, the Company's financial results, financial condition and operations).  The reader is cautioned that the foregoing list of assumptions and factors is not exhaustive, and there may be other factors listed in other filings with securities regulators, including factors set out in the Company's 2019 Annual MD&A under "Risk Management and Control Practices" and "Summary of Critical Accounting Estimates" and in the Company's annual information form dated February 12, 2020 under "Risk Factors", which, along with other filings, is available for review at www.sedar.com.  The reader is also cautioned to consider these and other factors, uncertainties and potential events carefully and not to place undue reliance on forward-looking information.  Other than as specifically required by applicable law, the Company does not intend to update any forward-looking information whether as a result of new information, future events or otherwise.

Cautionary note regarding Non-IFRS Financial Measures
This release contains some non-IFRS financial measures.  Terms by which non-IFRS financial measures are identified include, but are not limited to, "base earnings", "base earnings (US$)", "base earnings per common share", "return on equity", "base return on equity", "core net earnings", "constant currency basis", "impact of currency movement", "premiums and deposits", "pre-tax operating margin", "sales", "assets under management" and "assets under administration".  Non-IFRS financial measures are used to provide management and investors with additional measures of performance to help assess results where no comparable IFRS measure exists.  However, non-IFRS financial measures do not have standard meanings prescribed by IFRS and are not directly comparable to similar measures used by other companies.  Refer to the "Non-IFRS Financial Measures" section in the Company's first quarter of 2020 interim MD&A for the appropriate reconciliations of these non-IFRS financial measures to measures prescribed by IFRS as well as additional details on each measure.  

First quarter Conference Call
Lifeco's first quarter conference call and audio webcast will be held May 7, 2020 at 3:30 p.m. (ET).  The call and webcast can be accessed through http://www.greatwestlifeco.com/news-events/events or by phone at:

A replay of the call will be available from May 7 to June 7, 2020 and can be accessed by calling 1-855-669-9658 or 604-674-8052 (passcode: 4442#).  The archived webcast will be available on greatwestlifeco.com.

FINANCIAL HIGHLIGHTS (unaudited)
(in Canadian $ millions except per share amounts)


As at or for the three months ended


March 31
2020

December 31
2019

March 31
2019

Earnings




Base earnings(1)(4)

$

543

$

831

$

569

Net earnings - common shareholders

342

513

657

Per common share




Basic:




Base earnings(1)(4)

0.585

0.895

0.576

Net earnings

0.369

0.552

0.665

Diluted net earnings

0.369

0.552

0.665

Dividends paid

0.438

0.413

0.413

Book value

22.34

21.53

22.07

Base return on equity(1)(2)(4)

13.4%

13.3%

11.0%

Return on equity(1)(2)

10.3%

11.7%

13.5%





Total premiums and deposits(1)

$

46,365

$

39,096

$

40,845

Fee and other income

1,441

1,515

1,479

Net policyholder benefits, dividends and experience refunds

9,429

10,003

8,987





Total assets

$

436,903

$

451,167

$

442,492

Proprietary mutual funds and institutional net assets(1)

288,309

320,548

304,230

Total assets under management(1)

725,212

771,715

746,722

Other assets under administration(1)

798,847

857,966

804,202

Total assets under administration(1)

$

1,524,059

$

1,629,681

$

1,550,924

Total equity

$

26,441

$

25,543

$

27,400





The Canada Life Assurance Company consolidated LICAT Ratio(3)

133%

135%

140%



(1) 

This metric is a non-IFRS measure.  Refer to the "Non-IFRS Financial Measures" section of the Company's March 31, 2020 Management's Discussion and Analysis for additional details.

(2) 

Refer to the "Return on Equity" section of the Company's March 31, 2020 Management's Discussion and Analysis for additional details.

(3) 

The Life Insurance Capital Adequacy Test (LICAT) ratio is based on the consolidated results of The Canada Life Assurance Company, Lifeco's major Canadian operating subsidiary.  Refer to the "Capital Management and Adequacy" section of the Company's March 31, 2020 Management's Discussion and Analysis for additional details.

(4) 

Effective the first quarter of 2020, the Company introduced an enhanced non-IFRS earnings measure.  Base earnings (loss) are defined as net earnings excluding the impact of actuarial assumption changes and management actions, direct equity and interest rate market impacts on insurance contract liabilities net of hedging, and items that management believes are not indicative of the Company's underlying business results.  These items would include restructuring costs, material legal settlements, material impairment charges related to goodwill and intangible assets, legislative tax changes and other tax impairments, and gains or losses related to the disposition of a business.

 

Base earnings and Net earnings - common shareholders (unaudited)



For the three months ended


March 31
2020

December 31
2019

March 31
2019

Base earnings(1)




Canada

$

273

$

274

$

257

United States

17

89

81

Europe

132

317

163

Capital and Risk Solutions

119

157

74

Lifeco Corporate

2

(6)

(6)

Lifeco base earnings(1)

$

543

$

831

$

569

Items excluded from base earnings(2)




Actuarial assumption changes and management actions(1)(2)

$

(52)

$

(78)

$

129

Market-related impact(1)(2)

(149)

(13)

(41)

Revaluation of a deferred tax asset(2)

?

(199)

?

Restructuring costs(2)

?

(36)

?

Net gain on Scottish Friendly transaction(2)

?

8

?

Items excluded from Lifeco base earnings(2)

$

(201)

$

(318)

$

88

Net earnings - common shareholders




Canada

$

151

$

188

$

283

United States

5

(121)

81

Europe

91

335

194

Capital and Risk Solutions

93

117

105

Lifeco Corporate

2

(6)

(6)

Lifeco net earnings - common shareholders

$

342

$

513

$

657



(1) 

This metric is a non-IFRS measure.  Refer to the "Non-IFRS Financial Measures" section of the Company's March 31, 2020 Management's Discussion and Analysis for additional details.

(2) 

Items excluded from base earnings, a non-IFRS measure.  Refer to the "Non-IFRS Financial Measures" section of the Company's March 31, 2020 Management's Discussion and Analysis for additional details.

 

SOURCE Great-West Lifeco Inc.


These press releases may also interest you

at 21:00
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...

at 17:20
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...

at 16:45
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...



News published on and distributed by: